Lumida
/ELA
⌘K
ELA

ELA

ELA
$13.46USD↓-1.54%-0.21 today

MARKET CAP

349.5M

P/E (TTM)

16.6x

FWD P/E

—

DAY RANGE

$13 – $14

52W RANGE

$7
$30

AI Summary

Stalk
StalkMedium

In a Stage 2 advancing context with strong breakout momentum, medium- and long-term biases remain bullish. However, price is now extreme overbought and extended well above rising EMAs, reducing execution timing edge. Recommended posture is to stalk for a pullback into the prior breakout zone or rising EMAs before initiating new positions.

  • ↑Q2 EPS $0.16 (+45% YoY), net income $4.17 M (+52%).
  • ↑Profit margin rose to 7.4% from 5.0%, boosting efficiency.
  • ↓Forward P/E 33x vs. 11x industry average signals overvaluation.
Full analysis →

Buying

7

institutions

Selling

1

institutions

New Positions

2

this quarter

Filing Period

Q2 2026

latest 13-F

13-F Holdings

Institution↕Action↕Shares Held↕Value↓Change↕Chg %↕Weight↕
BI

Blackrock, Inc.

Q2 2026

BUY410.55 K11.86 M+97.51 K+127.3%0.00%
RT

Renaissance Technologies LLC

Q2 2026

BUY262.87 K7.59 M+1.86 K+74.6%0.01%
CA

Citadel Advisors LLC

Q2 2026

BUY39.30 K1.13 M+9.66 K+129.8%0.00%
MM

Millennium Management LLC

Q2 2026

BUY34.06 K983.68 K+12.53 K+174.2%0.00%
PA

Point72 Asset Management, L.P.

Q2 2026

BUYNEW18.09 K522.32 K+18.09 K+0.0%0.00%
AC

Aqr Capital Management LLC

Q2 2026

BUYNEW9.11 K263.10 K+9.11 K+0.0%0.00%
JC

Jpmorgan Chase & Co

Q2 2026

BUY3.10 K88.64 K+173.00+80.0%0.00%
BH

Brevan Howard Capital Management LP

Q2 2026

SELL0.000.00+-10.08 K-100.0%0.00%